Home Tonometry Diurnal Intraocular Pressure Patterns, Patient Adherence, and Measurement Reliability in a Prospective Clinical Cohort
- PMID: 41036067
- PMCID: PMC12482958
- DOI: 10.2147/OPTH.S545165
Home Tonometry Diurnal Intraocular Pressure Patterns, Patient Adherence, and Measurement Reliability in a Prospective Clinical Cohort
Abstract
Purpose: Assess patient adherence, diurnal intraocular pressure patterns, and correlation with in-office tonometry of home intraocular pressure monitoring (IOP).
Patients and methods: In this prospective cohort study, 75 patients with open-angle disease (150 eyes) were recruited and loaned the iCare HOME2 tonometer (ICH2) after in-person training and instructed to take 6 measurements per day for 10 ± 4 days. Statistical analysis of adherence, diurnal IOP patterns, and correlation with in-office tonometry was conducted.
Results: Most patients had good adherence (65% of patients took ≥ 6 measurements per day, median 7.4 measurements/day). However, adherence was poor for a notable minority of patients (19% of patients took less than 2 measurements per day). Patients with low adherence reported difficulty obtaining measurements and desire for more training with the ICH2 device. ICH2 identified diurnal patterns of IOP fluctuation: IOP varied significantly over the 24-hour day (p < 0.0001), and early morning peak IOP at 3 AM decreased significantly throughout the day to minimum mean IOP at 10 PM (p < 0.0001). IOP variance was significantly greater outside of clinic hours (p < 0.0001) and 36% of patients had maximum IOP outside of clinic hours. In-office IOP measurements had significant positive correlation to the closest ICH2 measurement obtained by the patient in time for both Goldman applanation (r2 = 0.35, p < 0.0001) and iCare IC100 (r2 = 0.48, p < 0.0001).
Conclusion: ICH2 is clinically useable and effective for detecting out-of-office IOP spikes, diurnal IOP patterns, and IOP variation.
Keywords: glaucoma; home monitoring; intraocular pressure fluctuation; prospective.
© 2025 Perkins et al.
Conflict of interest statement
AL: Consultant: New World Medical, Abbvie, Nova Eye; Research funding: Nova Eye. The authors report no other conflicts of interest or competing interests in this work.
Figures






References
LinkOut - more resources
Full Text Sources